Pharmafile Logo
Pharmafocus logo
Advanced Search

Alzheimer’s

Showing 15 posts of 151 posts found.

heptares_logo

Heptares announces positive early-stage dementia trial results

February 10, 2016
Research and Development Alzheimer's, Alzheimers, Heptares, dementia, schizophrenia

Heptares has announced positive findings from its Phase 1b clinical study with its investigational drug HTL9936 as a treatment for …

News

Alzheimer’s drugs prescriptions rise six-fold in a decade

January 19, 2016
Manufacturing and Production Alzheimer's, Alzheimer's disease, NHSIC, dementia, prescribing

The number of prescriptions dispensed in England for approved medicines to treat Alzheimer’s increased from 502,000 in 2004 to 3 …

News
Alzheimer's brain

The case for adaptive trials in dementia

January 6, 2016
Manufacturing and Production, Research and Development Alzheimer's, Alzheimer's disease, adaptive trials, research

An ageing population and widespread chronic neuro-degenerative disease will make dementia an ever increasing burden on society, families and the …

Feature
alzheimers_brain

Lilly, Biogen and Roche debut Alzheimer’s disease drug results

July 22, 2015
Research and Development Alzheimer's, Alzheimer's disease, Biogen, Conference, Eli Lilly, Roche, lilly

Big pharma companies have posted mixed results in trials of several potential new treatments for Alzheimer’s disease. But the results, …

News
Abbvie image

AbbVie invests $30 million to expand in Puerto Rico

March 23, 2015
Manufacturing and Production, Sales and Marketing AbbVie, Alzheimer's, Puerto Rico, barceloneta, c2n

AbbVie is investing $30 million to expand one of its sites in Puerto Rico, and is also backing a promising …

News
Biogen image

Biogen shortens name and posts positive Alzheimer’s results

March 23, 2015
Sales and Marketing AD, Alzheimer's, BIIB037, Biogen, MS, Parkinson's, aducanumab, idec

Biogen Idec is to be known only as Biogen hence forth as the US biotech also reveals positive early results …

News
Biogen image

Big pharma partners with government over $100m dementia fund

March 17, 2015
Research and Development, Sales and Marketing Alzheimer's, Biogen IDEC, GSK, J&J, JJ, Pfizer, government, jp morgan, lilly

Lilly, Pfizer, GSK, J&J and Biogen Idec are set to join a $100m Dementia Discovery Fund to boost research into …

News
Eisai image

Eisai Alzheimer’s drug to see China review

March 4, 2015
Sales and Marketing Alzheimer's, Aricept, China, Eisai, donepezil hydrochloride

Alzheimer’s drug Aricept from Eisai has been accepted for review in China to treat patients with the most severe form …

News
Roche image

Roche dealt with two late-stage blows

December 19, 2014
Sales and Marketing Alzheimer's, Alzheimer’s, Cancer, Kadcyla, Perjeta, Roche, Xeloda, trastuzumab emtansine

Swiss giant Roche’s breast cancer treatment Kadcyla has failed to meet its primary endpoint and its investigational Alzheimer’s treatment trial …

News
Avanir image

Otsuka buys Avanir for $3.5 billion

December 3, 2014
Sales and Marketing Abilify, Alzheimer's, Alzheimer’s, Nuedexta, Otsuka, Parkinson's, Parkinson’s, avanir

Otsuka is to buy Avanir Pharmaceuticals for $3.5 billion as it looks to make up for the imminent patent expiry …

News
Lilly image

AZ and Lilly Alzheimer’s drug enters trials

December 1, 2014
Research and Development, Sales and Marketing AZD3293, Alzheimer's, AstraZeneca, LY3314814, lilly

AstraZeneca and Eli Lilly have begun a Phase II/II trial for their Alzheimer’s treatment AZD3293 as the companies hope to …

News
Boris image

Mayor of London calls for dementia R&D centre

October 8, 2014
Research and Development, Sales and Marketing Alzheimer's, Boris Johnson, London, dementia, research

The mayor of London Boris Johnson is calling on both the government and the private sector to come together and …

News
AZ image

AstraZeneca teams up with rival Lilly for Alzheimer’s

September 16, 2014
Research and Development, Sales and Marketing AZD3293, Alzheimer's, Alzheimer’s, AstraZeneca, BACE, lilly

AstraZeneca and US rival Lilly have signed an agreement to develop a new and experimental pill for the treatment of …

News
David Cameron PM

Dementia diagnoses on the rise

July 30, 2014
Medical Communications, Research and Development, Sales and Marketing Alzheimer's, david cameron, dementia

The number of patients in England diagnosed with dementia has increased by 62% over seven years according to provisional figures …

News

Mixed bag for Genentech dementia drug

July 18, 2014
Research and Development, Sales and Marketing Alzheimer's, Genentech, crenezumab, dementia

A Phase II clinical trial for Genentech’s investigational Alzheimer’s drug failed to meet its primary endpoints – but the company …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025